申请人:RATIOPHARM GMBH
公开号:WO2013188829A1
公开(公告)日:2013-12-19
The invention relates to substantially pure Desfesoterodine salts, Desfesoterodine salts, solid state forms thereof and pharmaceutical compositions comprising one or more of the Desfesoterodine salts and/or solid state forms thereof.
这项发明涉及基本纯度的Desfesoterodine盐、Desfesoterodine盐、其固态形式以及包含一种或多种Desfesoterodine盐和/或其固态形式的药物组合物。